Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,515 | -120,809 | -96,571 | -64,674 | -30,677 |
| Depreciation Amortization | 1,734 | 5,789 | 3,335 | 1,941 | 911 |
| Income taxes - deferred | -93 | -575 | -423 | -373 | -145 |
| Accounts receivable | N/A | N/A | N/A | -358 | N/A |
| Accounts payable and accrued liabilities | 725 | 888 | 321 | 84 | -737 |
| Other Working Capital | 2,546 | 3,842 | 3,606 | 2,599 | 819 |
| Other Operating Activity | 9,546 | 72,272 | 61,892 | 43,624 | 20,973 |
| Operating Cash Flow | $-10,057 | $-38,593 | $-27,840 | $-17,157 | $-8,856 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,047 | -107,112 | -100,006 | -109,940 | -100,845 |
| PPE Investments | -4,509 | -6,560 | -5,202 | -2,123 | -1,067 |
| Purchase Of Investment | -8,500 | N/A | N/A | 0 | N/A |
| Investing Cash Flow | $16,038 | $-113,672 | $-105,208 | $-112,063 | $-101,912 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -22 | -32 | -10 | 0 | 0 |
| Common Stock Issued | 1,154 | 1,425 | 1,044 | 859 | 660 |
| Common Stock Repurchased | -1,050 | -15,847 | -11,898 | -9,324 | -2,550 |
| Other Financing Activity | -550 | -1,106 | -592 | 0 | 0 |
| Financing Cash Flow | $-468 | $-15,560 | $-11,456 | $-8,465 | $-1,890 |
| Beginning Cash Position | 8,262 | 176,087 | 175,908 | 175,908 | 175,908 |
| End Cash Position | 13,775 | 8,262 | 31,404 | 38,223 | 63,250 |
| Net Cash Flow | $5,513 | $-167,825 | $-144,504 | $-137,685 | $-112,658 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,057 | -38,593 | -27,840 | -17,157 | -8,856 |
| Capital Expenditure | -4,509 | -6,560 | -5,202 | -2,123 | -1,067 |
| Free Cash Flow | -14,566 | -45,153 | -33,042 | -19,280 | -9,923 |